View in EDS

Azeliragon attenuates cerebral infarction aggravation in diabetic rats: Receptor for advanced glycation end-product as a novel therapeutic target.

Saved in:
Bibliographic Details
Title: Azeliragon attenuates cerebral infarction aggravation in diabetic rats: Receptor for advanced glycation end-product as a novel therapeutic target.
Authors: Lee JS; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea. Electronic address: jinsoo22@gmail.com., Yoon BS; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea., Lee SJ; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea., Park SY; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea., Joe EH; Department of Pharmacology, Ajou University School of Medicine, Suwon, Republic of Korea., Oh YJ; Institute for Convergence Research and Education in Advanced Technology, Yonsei University, Incheon, Republic of Korea; GNT Pharma Science and Technology Center for Health, Incheon, Republic of Korea., Choi EJ; GNT Pharma Science and Technology Center for Health, Incheon, Republic of Korea; Division of Life Sciences, College of Life Sciences, Korea University, Seoul, Republic of Korea.
Source: Experimental neurology [Exp Neurol] 2026 Mar; Vol. 397, pp. 115588. Date of Electronic Publication: 2025 Dec 09.
Publication Type: Journal Article
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2430 (Electronic) Linking ISSN: 00144886 NLM ISO Abbreviation: Exp Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41380793
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Azeliragon attenuates cerebral infarction aggravation in diabetic rats: Receptor for advanced glycation end-product as a novel therapeutic target.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea. Electronic address: jinsoo22@gmail.com.<br /><searchLink fieldCode="AU" term="%22Yoon+BS%22">Yoon BS</searchLink>; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SJ%22">Lee SJ</searchLink>; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+SY%22">Park SY</searchLink>; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Joe+EH%22">Joe EH</searchLink>; Department of Pharmacology, Ajou University School of Medicine, Suwon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Oh+YJ%22">Oh YJ</searchLink>; Institute for Convergence Research and Education in Advanced Technology, Yonsei University, Incheon, Republic of Korea; GNT Pharma Science and Technology Center for Health, Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+EJ%22">Choi EJ</searchLink>; GNT Pharma Science and Technology Center for Health, Incheon, Republic of Korea; Division of Life Sciences, College of Life Sciences, Korea University, Seoul, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370712%22">Experimental neurology</searchLink> [Exp Neurol] 2026 Mar; Vol. 397, pp. 115588. <i>Date of Electronic Publication: </i>2025 Dec 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370712 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1090-2430 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200144886%22">00144886 </searchLink><i>NLM ISO Abbreviation: </i>Exp Neurol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41380793
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.expneurol.2025.115588
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115588
    Titles:
      – TitleFull: Azeliragon attenuates cerebral infarction aggravation in diabetic rats: Receptor for advanced glycation end-product as a novel therapeutic target.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee JS
      – PersonEntity:
          Name:
            NameFull: Yoon BS
      – PersonEntity:
          Name:
            NameFull: Lee SJ
      – PersonEntity:
          Name:
            NameFull: Park SY
      – PersonEntity:
          Name:
            NameFull: Joe EH
      – PersonEntity:
          Name:
            NameFull: Oh YJ
      – PersonEntity:
          Name:
            NameFull: Choi EJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1090-2430
          Numbering:
            – Type: volume
              Value: 397
          Titles:
            – TitleFull: Experimental neurology
              Type: main
ResultId 1